- Home
- GNK vs ATTO Comparison
GNK vs ATTO Comparison
Compare GNK & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNK | ATTO |
|---|---|---|
| Founded | 2004 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2005 | 2026 |
Fundamental Metrics
Financial Performance| Metric | GNK | ATTO |
|---|---|---|
| Price | $27.19 | $17.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $29.36 | ★ $42.20 |
| AVG Volume (30 Days) | ★ 541.5K | 273.6K |
| Earning Date | 11-04-2026 | 09-02-2026 |
| Dividend Yield | ★ 3.63% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.58 | N/A |
| Revenue | ★ $342,054,000.00 | N/A |
| Revenue This Year | $13.34 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $45.34 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.56 | $16.15 |
| 52 Week High | $28.42 | $28.00 |
Technical Indicators
Market Signals| Indicator | GNK | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 37.37 |
| Support Level | $25.74 | $16.39 |
| Resistance Level | $26.68 | $24.89 |
| Average True Range (ATR) | 0.82 | 1.99 |
| MACD | -0.18 | -0.58 |
| Stochastic Oscillator | 20.44 | 10.75 |
Price Performance
Historical ComparisonAbout GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.